ChemoCommunity

Characterizing chemoresponse communities at transcriptional and post-transcriptional levels.

Compound Details

The detailed records of NSC 5332 were elucidated in the following 4 sections: 1) Basis: basic information about NSC 5332; 2) Community: the network communities that were significantly associated with the response to NSC 5332; 3) Molecule: the relationships between components within communities and NSC 5332; 4) MDR: the compounds that were significantly associated with the NSC 5332.

NSC Compound Enrichment Correlation
NSC 749292 3-methoxy-1-nitrosopyrido[3,2:4,5]pyrrolo[1,2-c][1,2,3]benzotriazine 0.0147237897640499 0.61199061
NSC 757949 (1R,2E,6R,10E,11aS,13S,14aR)-6-(2-(benzyloxy)ethyl)-1,13-dihydroxy-6,7,8,9,12,13,14,14a-octahydro-1H-cyclopenta[f][1]oxacyclotridecin-4(11aH)-one 0.0147237897640499 -0.30553646
NSC 763646 (E)-2-(2-(benzo[d][1,3]dioxol-5-yl)vinyl)-5-(3-methyl-1H-pyrazol-5-yl)-1,3,4-oxadiazole 0.0147237897640499 0.23483367
NSC 96996 B 169 0.0147237897640499 0.25496599
NSC 615804 ANTINEOPLASTIC-615804 0.0164116791870034 0.21286409
NSC 633362 Null 0.0164116791870034 -0.40823621
NSC 639365 1-(3-Diethylamino-2-hydroxypropylamine)-4-(3-chloro-2- hydroxypropylamine)anthraquinone 0.0164116791870034 0.46441232
NSC 649890 Alvocidib hydrochloride, 0.0164116791870034 0.15642582
NSC 658372 Null 0.0164116791870034 0.14523095
NSC 676372 Null 0.0164116791870034 0.11786418
Total:103  Current:47    [First] [Prev] [Next] [Last]